Listen here, or download the 37 MB mp3 file.
Focusing on unmet needs, healthcare entrepreneurs provide their in-the-trenches perspectives on advancing medical technologies. Working to extend and enhance lives. Especially in global markets that demand high-impact growth products, innovators are challenged by securing funding through traditional ventures or alternative sources and developing cost-effective products in a changing landscape. From the 2011 Global Health Series organized by the Stanford Global Health Center in partnership with the Stanford Graduate School of Business, Paul Yock, Professor of Medicine and Founding Co-Chair of Stanford’s Program in Biodesign, leads this interactive panel discussion. Panelists include Uday Kumar of iRhythm, Darin Buxbaum of Hourglass Technologies, Mohit Kaushal of the West Wireless Health Institute, and Darren Hite of Aberdare Ventures, all of whom launched in their first years after Stanford.
Efforts to bring promising health care interventions to resource-constrained regions of the world often falter because entrepreneurs underestimate the array of obstacles that loom in their path.
By predicting vulnerability, biological science can help families, communities, clinicians, and policymakers develop more effective responses to a troubling health challenge.